NY - Support S3295, the Crohn's & Colitis Fairness Act

We apologize, but the action alert you are attempting to access is no longer active.

Consider taking action on other issues.

Support IBD Medical Research Funding

Take action on this issue

Congress is deliberating on funding for key medical research agencies that study IBD. Ask your legislators to support agencies that study IBD!

Call your Senators to draft a better healthcare plan

Take action on this issue

Call your Senators to vote NO on the current healthcare proposals and to go back to the drawing board to craft a better plan that supports the chronic illness community with patient input.

Request Funding for CDC's IBD Program!

Take action on this issue

The Centers for Disease Control and Prevention (CDC) has led an epidemiological study of IBD to understand IBD incidence, prevalence, demographics, and healthcare utilization. Since, 2006 CDC epidemiologists have been working in conjunction with CCFA.

Support the inclusion of IBD in the Department of Defense's Peer-Reviewed Medical Research Program

Take action on this issue

Currently, Congress is considering providing funding for IBD research at the Department of Defense's Peer-Reviewed Medical Research Program (PRMRP). The Peer-Reviewed Medical Research Program provides expanded research at the Department of Defense.

Support Restoring the Patient's Voice Act

Take action on this issue

HR 2077, Restoring the Patient's Voice Act, would help patients access medications in a timely manner by establishing circumstances in which a patient can be exempt from insurance plan step therapy protocols when medically appropriate.

Tell Senators to draft a better healthcare plan

Take action on this issue

Tell the Senate to vote No on the healthcare proposals and to go back to the drawing board to craft a better plan to improve the nation's healthcare system with patient input.

Support The Patients' Access to Treatments Act!

Take action on this issue

Ask your House Representative to co-sponsor The Patients' Access to Treatments Act which would limit patient co-pays for complex and expensive medications.